Literature DB >> 25746972

TH9 cells are required for tissue mast cell accumulation during allergic inflammation.

Sarita Sehra1, Weiguo Yao1, Evelyn T Nguyen1, Nicole L Glosson-Byers2, Nahid Akhtar1, Baohua Zhou3, Mark H Kaplan4.   

Abstract

BACKGROUND: IL-9 is important for the growth and survival of mast cells. IL-9 is produced by T cells, natural killer T cells, mast cells, eosinophils, and innate lymphoid cells, although the cells required for mast cell accumulation during allergic inflammation remain undefined.
OBJECTIVE: We sought to elucidate the role of TH9 cells in promoting mast cell accumulation in models of allergic lung inflammation.
METHODS: Adoptive transfer of ovalbumin-specific TH2 and TH9 cells was used to assess the ability of each subset to mediate mast cell accumulation in tissues. Mast cell accumulation was assessed in wild-type mice and mice with PU.1-deficient T cells subjected to acute and chronic models of allergic inflammation.
RESULTS: Adoptive transfer experiments demonstrated that recipients of TH9 cells had significantly higher mast cell accumulation and expression of mast cell proteases compared with control or TH2 recipients. Mast cell accumulation was dependent on IL-9, but not IL-13, a cytokine required for many aspects of allergic inflammation. In models of acute and chronic allergic inflammation, decreased IL-9 levels in mice with PU.1-deficient T cells corresponded to diminished tissue mast cell numbers and expression of mast cell proteases. Mice with PU.1-deficient T cells have defects in IL-9 production from CD4(+) T cells, but not natural killer T cells or innate lymphoid cells, suggesting a TH cell-dependent phenotype. Rag1(-/-) mice subjected to a chronic model of allergic inflammation displayed reduced mast cell infiltration comparable with accumulation in mice with PU.1-deficient T cells, emphasizing the importance of IL-9 produced by T cells in mast cell recruitment.
CONCLUSION: TH9 cells are a major source of IL-9 in models of allergic inflammation and play an important role in mast cell accumulation and activation.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PU.1; T(H)2 cells; T(H)9 cells; allergic inflammation; mast cells

Mesh:

Substances:

Year:  2015        PMID: 25746972      PMCID: PMC4530056          DOI: 10.1016/j.jaci.2015.01.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  51 in total

Review 1.  Signalling through the high-affinity IgE receptor Fc epsilonRI.

Authors:  H Turner; J P Kinet
Journal:  Nature       Date:  1999-11-25       Impact factor: 49.962

2.  Interleukin-9 upregulates mucus expression in the airways.

Authors:  J Louahed; M Toda; J Jen; Q Hamid; J C Renauld; R C Levitt; N C Nicolaides
Journal:  Am J Respir Cell Mol Biol       Date:  2000-06       Impact factor: 6.914

3.  Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1.

Authors:  M Stassen; M Arnold; L Hültner; C Müller; C Neudörfl; T Reineke; E Schmitt
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 4.  The diverse potential effector and immunoregulatory roles of mast cells in allergic disease.

Authors:  C M Williams; S J Galli
Journal:  J Allergy Clin Immunol       Date:  2000-05       Impact factor: 10.793

5.  Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

Authors:  C Uyttenhove; R J Simpson; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells.

Authors:  M Longphre; D Li; M Gallup; E Drori; C L Ordoñez; T Redman; S Wenzel; D E Bice; J V Fahy; C Basbaum
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model.

Authors:  T Kobayashi; T Miura; T Haba; M Sato; I Serizawa; H Nagai; K Ishizaka
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes.

Authors:  Veit J Erpenbeck; Jens M Hohlfeld; Brunhild Volkmann; Andreas Hagenberg; Henning Geldmacher; Armin Braun; Norbert Krug
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

9.  A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma.

Authors:  Leonie S van Rijt; Harmjan Kuipers; Nanda Vos; Daniëlle Hijdra; Henk C Hoogsteden; Bart N Lambrecht
Journal:  J Immunol Methods       Date:  2004-05       Impact factor: 2.303

10.  Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant.

Authors:  Christian Taube; Xudong Wei; Christina H Swasey; Anthony Joetham; Simona Zarini; Tricia Lively; Katsuyuki Takeda; Joan Loader; Nobuaki Miyahara; Taku Kodama; Lenny D Shultz; Debra D Donaldson; Eckard H Hamelmann; Azzeddine Dakhama; Erwin W Gelfand
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  69 in total

Review 1.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

2.  Stimulation of histamine H4 receptors increases the production of IL-9 in Th9 polarized cells.

Authors:  Katrin Schaper-Gerhardt; Mareike Wohlert; Susanne Mommert; Manfred Kietzmann; Thomas Werfel; Ralf Gutzmer
Journal:  Br J Pharmacol       Date:  2019-02-21       Impact factor: 8.739

Review 3.  Pathogenic CD4+ T cells in patients with asthma.

Authors:  Lyndsey M Muehling; Monica G Lawrence; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-04-22       Impact factor: 10.793

Review 4.  The use of biologics for immune modulation in allergic disease.

Authors:  Willem van de Veen; Mübeccel Akdis
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

Review 5.  TH9 cells in skin disorders.

Authors:  Rachael A Clark; Christoph Schlapbach
Journal:  Semin Immunopathol       Date:  2016-11-28       Impact factor: 9.623

Review 6.  Th9 and other IL-9-producing cells in allergic asthma.

Authors:  Sonja Koch; Nina Sopel; Susetta Finotto
Journal:  Semin Immunopathol       Date:  2016-11-17       Impact factor: 9.623

Review 7.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

8.  Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection.

Authors:  Meilan Cui; Ying Lv; Jianhua Lu; Wei Zhang; Yuanyuan Duan; Yan Huang; Lei Yang; Man Li; Wenxuan Liu; Dianwu Liu; Huimin Yan
Journal:  J Clin Lab Anal       Date:  2017-05-08       Impact factor: 2.352

Review 9.  Dysregulated Th1 Immune and Vascular Responses in Scrub Typhus Pathogenesis.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2018-02-15       Impact factor: 5.422

10.  The ETS Family Transcription Factors Etv5 and PU.1 Function in Parallel To Promote Th9 Cell Development.

Authors:  Byunghee Koh; Matthew M Hufford; Duy Pham; Matthew R Olson; Tong Wu; Rukhsana Jabeen; Xin Sun; Mark H Kaplan
Journal:  J Immunol       Date:  2016-08-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.